The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 115.00
Ask: 118.00
Change: 8.00 (7.37%)
Spread: 3.00 (2.609%)
Open: 108.50
High: 117.50
Low: 107.00
Prev. Close: 108.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options to employees

22 Feb 2022 07:02

RNS Number : 3478C
Transense Technologies PLC
22 February 2022
 

 

Transense Technologies plc

("Transense" or "the Company")

 

Grant of share options to employees

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that it has today granted 93,000 options to acquire ordinary shares in the Company to employees. The options have an exercise price of 79.5 pence per share and can be exercised after three years until the tenth anniversary of grant. None of these options were granted to directors, and they carry specific exercise conditions related to the future financial performance of relevant business segments.

In order to create sufficient capacity to grant these options within the current approved limit of 10% of issued share capital, Chief Financial Officer Melvyn Segal has elected to waive 50,000 share options granted to him on 26 June 2017 and which will be cancelled.

Following this announcement, there are now 1,582,000 unexercised share options currently in issue under active Company schemes, representing approximately 9.62% of the current issued share capital of the Company.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

Notes to Editors:

Transense develops and supplies wireless sensor technology and systems. The company has three business areas:

· SAW, patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik, smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack, a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

 

For further information please contact transense@walbrookpr.com.

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Melvyn Segal

2

 

Reason for the notification

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

 

 

Identification code

GB00BDHDTH21

 

 

b)

 

Nature of the transaction 

 

Cancellations of options

c)

Price and volume

Price: n/a

 

Volume: 50,000

d)

 

Aggregated information

 

 

 

- Aggregated volume

As above

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

22 February 2022

f)

 

Place of the transaction

 

Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEUESFEESESE
Date   Source Headline
25th Jun 20188:29 amRNSHolding(s) in Company
21st Jun 20182:33 pmRNSResult of General Meeting
31st May 20187:00 amRNSPlacing and Notice of General Meeting
8th May 20187:00 amRNSNew Translogik iTrack Contract Win
2nd Mar 201812:26 pmRNSStatement re joint broker
7th Feb 20187:00 amRNSInterim Results
5th Feb 20189:56 amRNSHolding(s) in Company
21st Dec 20171:09 pmRNSResult of AGM
21st Dec 20177:00 amRNSAGM Statement
18th Dec 201711:18 amRNSIssue of Equity
27th Nov 20179:29 amRNSContract Win
14th Nov 20177:00 amRNSNotice of AGM
26th Sep 20177:00 amRNSFinal Results
5th Sep 20177:00 amRNSNotice of Results
5th Sep 20177:00 amRNSInvestor Event
7th Aug 20177:00 amRNSNew iTrack Contract Win with BHP in Australia
31st Jul 20177:00 amRNSTrading Update
27th Jun 20177:00 amRNSAward of options
26th Jun 20177:00 amRNSGlencore - Further Contract Win
6th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSGlencore - Further Contract Win
4th Apr 20175:20 pmRNSHolding(s) in Company
29th Mar 20177:01 amRNSInterim results
29th Mar 20177:00 amRNSFurther Payment from General Electric
1st Mar 20177:00 amRNSInvestor Event
28th Feb 20171:54 pmRNSNotice of Results
27th Jan 20177:00 amRNSIssue of Equity
22nd Dec 20168:19 amRNSCapital Reduction
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation
23rd Nov 20167:00 amRNSAGM Statement
21st Sep 20167:00 amRNSNotice of AGM
21st Sep 20167:00 amRNSFinal Results
25th Aug 20167:00 amRNSInvestor Event
16th Aug 20167:00 amRNSNotice of Results
18th Jul 20167:01 amRNSTrading Update
18th Jul 20167:00 amRNSLicence Agreement with GE
9th Mar 20162:55 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSInterim Results
16th Dec 20157:00 amRNSTranslogik Contract Win with Continental
16th Nov 20153:55 pmRNSResult of AGM
16th Nov 20157:00 amRNSAGM Statement
22nd Oct 20157:00 amRNSDirector Dealing
21st Oct 20157:00 amRNSSale of IntelliSAW Division for US$5m
8th Oct 20157:00 amRNSNotice of AGM and Posting of Accounts
28th Sep 20157:00 amRNSPreliminary unaudited results
13th Aug 20157:00 amRNSNew Translogik iTrack Contract Win
29th Jul 201512:36 pmRNSHolding(s) in Company
27th Jul 20151:30 pmRNSResult of General Meeting
27th Jul 20157:00 amRNSGM Statement & Result of Offer for Subscription
16th Jul 20157:00 amRNSRe: Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.